
European pharmacy chain Alliance Boots has signed a strategic deal with China’s Nanjing Pharmaceutical Company, it has been announced.
Under the terms of the deal, Alliance Boots will acquire a 12 per cent stake in Nanjing Pharmaceutical for approximately £56 million (RMB560 million). On completion of the transaction, Alliance Boots will be the second largest shareholder in Nanjing Pharmaceutical with board and operational management representation. Nanjing Pharmaceutical Group Limited will continue to be the largest shareholder in the Chinese company.